Platform Innovation: Presenting ELLA™ Simple Plex Validation Data at the European User Meeting

As one of the select few Contract Research Organisations in the UK equipped to offer the ELLA™ Simple Plex automated immunoassay platform as a commercial service, Tetrad Discovery was privileged to participate in ProteinSimple’s inaugural European ELLA User Meeting.

Spanning two days of intensive technical discourse, the symposium brought together leading bio-analytical practitioners to explore next-generation microfluidic applications and multiplexing developments. For the Tetrad team, the event served as a crucial forum to exchange operational workflows, benchmark sub-picogram assay sensitivity, and remain at the absolute vanguard of automated protein analysis.

A central highlight of the conference was the presentation of original validation data by Tetrad Senior Scientist Rachel Doyle. Showcasing an in-house project executed in direct collaboration with ProteinSimple, the poster detailed the commercial co-development and validation of a novel analyte for the platform’s expanding global assay catalogue.

"Collaborating with platform developers to push the boundaries of what an instrument can detect is where an agile CRO provides true value," the Tetrad team noted. "We extend our thanks to ProteinSimple for facilitating an exceptional meeting of scientific minds, and look forward to deploying these expanded ELLA capabilities for our pre-clinical sponsors."